Psoriasiform graft‐versus‐host disease responded to secukinumab: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Psoriasiform graft‐versus‐host disease responded to secukinumab: A case report

Published:2023-08-31 Issue:4 Volume:64 Page:534-536
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Aust J Dermatology

Author:

Gu Ying¹^ORCID,Sun Jing¹,Zhang Jianzhong²

Affiliation:

1. Department of Dermatology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing China

2. Department of Dermatology Peking University People's Hospital Beijing China

Abstract

AbstractWe describe a 9‐year‐old boy who developed generalised erythematous lesions 12 months after haematopoietic stem cell transplant (HSCT). Histopathology showed both features of psoriasis and graft‐versus‐host disease (GVHD). The lesions responded well to secukinumab, suggesting that IL‐17A monoclonal antibody might be a treatment option for GVHD.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.14144

Reference11 articles.

1. Targeting the IL17 Pathway for the Prevention of Graft-Versus-Host Disease

2. Chronic Graft-Versus-Host Disease Mimicking Psoriasis in a Patient with Hemophagocytic Lymphohistiocytosis

3. Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease

4. A Case of Acute Cutaneous Graft-versus-Host Disease Mimicking Psoriasis Vulgaris

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP